The FDA Patient & Caregiver Connection: Impacting Innovations in Patient Care and Treatment

Melinda Starling
As an extension of AAKP’s National Strategy, AAKP participates in key initiatives that allow us to engage kidney patients in substantive and meaningful efforts designed to impact research over the long-term and help lead to new innovations for medical devices (including diagnostics)
Read More

Innovator Series: Aurinia Pharmaceuticals, Inc.

Melinda Starling
By Robert Huizinga, Ph.D., R.N., CNeph©, Executive Vice President, Corporate Development and Neil Solomons, MD, Chief Medical Officer at Aurinia Pharmaceuticals1. Tell us about your first experience with a kidney patient, personal or professional, and what impressions that left on you as a fellow human being. RH:
Read More

How Are We Going to Open Up Safely?

Melinda Starling
By Stephen Z. Fadem, MD, FASN, Chairman, Medical Advisory Board AAKPIntroduction The COVID-19 pandemic has taken the world by surrise and been costly in terms of life. As of May 27, 2020, there were over 100,000 deaths related to COVID-19 in the United States. By June 8, another 11,700 had died (Source: https://coronavirus.jhu.edu/map.html)
Read More

Kent’s Kidney Stories with AAKP Ambassador Risa Simon

Melinda Starling
During this episode of Kent’s Kidney Stories, AAKP BOD member/ambassador Kent Bressler speaks with fellow ambassador Risa Simon on the tenth anniversary of her successful kidney transplant.On June 8, 2010, Risa received her transplant from a living donor, which was considered preemptive, and therefore allowed her to bypass dialysis.
Read More